SANDY JACKSON: Open Payments
NPI 1043671530 · CUBA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 87 payments from 17 companies in 2025. Trend: 2023 $2,547 · 2024 $2,432 · 2025 $1,603
Food & beverage: $1,603
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $350 |
| GlaxoSmithKline, LLC. | 20 | $259 |
| Novo Nordisk Inc | 14 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $159 |
| Lilly USA, LLC | 5 | $113 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| PFIZER INC. | 4 | $76 |
| Abbott Laboratories | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
Products named: FARXIGA, TRELEGY ELLIPTA, Ozempic, CAPLYTA, JARDIANCE, AIRSUPRA, Auvelity, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
